Review of the safety with biologics in inflammatory bowel disease

Biologics have completely changed the treatment (and life) of patients with inflammatory bowel disease (IBD). After the first ones, anti-tumor necrosis factor (TNF) biologics, two new biologics, with other therapeutic targets, are now in routine use in our patients, and some others are in different...

Full description

Bibliographic Details
Main Authors: Andrea Pascual, Raquel Vicente, Eva Sierra, Santiago García-López
Format: Article
Language:English
Published: Publicaciones Permanyer 2022-07-01
Series:Journal of IMIDs
Subjects:
Online Access:https://www.journalofimids.com/frame_esp.php?id=21